BIT
ARRY

BlackRock Institutional Trust’s Array Biopharma Inc ARRY Stock Holding History

BlackRock Institutional Trust’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$39.3M Buy
4,467,957
+737,440
+20% +$5.43M 0.01% 1500
2016
Q3 		$25.2M Buy
3,730,517
+257,664
+7% +$997K ﹤0.01% 1714
2016
Q2 		$12.4M Buy
3,472,853
+31,629
+0.9% +$103K ﹤0.01% 2161
2016
Q1 		$10.2M Buy
3,441,224
+16,313
+0.5% +$48.9K ﹤0.01% 2246
2015
Q4 		$14.5M Buy
3,424,911
+49,312
+1% +$225K ﹤0.01% 2089
2015
Q3 		$15.4M Sell
3,375,599
-482,735
-13% -$2.86M ﹤0.01% 2011
2015
Q2 		$27.8M Sell
3,858,334
-192,958
-5% -$1.42M ﹤0.01% 1693
2015
Q1 		$29.9M Buy
4,051,292
+79,429
+2% +$565K ﹤0.01% 1664
2014
Q4 		$18.8M Buy
3,971,863
+23,920
+0.6% +$94.6K ﹤0.01% 1952
2014
Q3 		$14.1M Buy
3,947,943
+209,248
+6% +$825K ﹤0.01% 2104
2014
Q2 		$17M Sell
3,738,695
-14,538
-0.4% -$60.1K ﹤0.01% 2070
2014
Q1 		$17.6M Buy
3,753,233
+307,996
+9% +$1.55M ﹤0.01% 2046
2013
Q4 		$17.3M Buy
3,445,237
+270,917
+9% +$1.47M ﹤0.01% 2058
2013
Q3 		$19.7M Sell
3,174,320
-1,347,122
-30% -$8M ﹤0.01% 1857
2013
Q2 		$20.5M Buy
+4,521,442
New +$24.3M ﹤0.01% 1792

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock Institutional Trust's ARRY Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Array Biopharma Inc (ARRY) stake by 20% in Q4 2016, buying an estimated $5.43M and bringing the position to 4,467,957 shares worth $39.3M. The position accounts for 0.01% of the portfolio, ranked #1500.

BlackRock Institutional Trust first reported a position in ARRY in Q2 2013 and has held it in 15 quarters since. 167 funds tracked by Wall St. Rank hold ARRY as of Q4 2016.

  • BlackRock Institutional Trust held 4,467,957 shares of Array Biopharma Inc worth $39.3M as of Q4 2016.
  • BlackRock Institutional Trust bought 737,440 Array Biopharma Inc shares in Q4 2016, an estimated $5.43M.
  • Array Biopharma Inc made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1500 holding.
  • BlackRock Institutional Trust first reported a position in Array Biopharma Inc in Q2 2013 and has held it in 15 quarters since.
  • 167 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.